Form EFFECT GT Biopharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ELEKTROS Inc. Accelerates Its EV Infrastructure Vision With Planned High-Speed Charging Network and Strategic Growth Initiative
- Qivurn Data Centers Inc. Secures Dual U.S. Financial Regulatory Licenses, Laying a Solid Foundation for Global Strategic Financing Compliance
- Render Price Prediction After 89% Decline While Pepeto Presale Offers a Different Path
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
